Med Fusion Selects N-of-One

News   Nov 09, 2016

 
Med Fusion Selects N-of-One
 
 
 
 

RELATED ARTICLES

Biofortuna Raises £1.6 Million in Funding Round

News

Biofortuna Ltd has raised £1.6 million, allowing the company to take its blood group genotyping assays into clinical trails and commercialisation.

READ MORE

Mercury Is Altering Gene Expression

News

New research claims that mercury found in highly contaminated fish can cause irreversible neurological disorders in people who have consumed them.

READ MORE

Immunotherapy to Treat Type 1 Diabetes

News

Researchers at King’s College London and Cardiff University observed noticeable changes in the behavior of the immune systems of type 1 diabetes patients that had been injected with peptides.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE